A new method uses the auxin-inducible degron (AID) system to tune protein levels with precision in living C. elegans.

The hydrogel preservation technology maintains cell viability for days at room temperature, removing cold-chain constraints.

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

Researchers at the Keck School of Medicine of University of Southern California (USC) have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response ...

A new brain-computer interface promises ultra-high resolution neural recording and wireless operation in a very small form.

Cosmo Pharmaceuticals attracted welcome attention from investors and other market watchers after coming out with topline ...

A new automated process for engineering tumor-targeting T cells could help accelerate personalized cancer treatments—while easing the physical toll on patients. Richard C. Koya, MD, PhD, who directs ...

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

In future, a more detailed understanding of the lung microbiome in pneumonia may enable improved diagnostics, prognosis, and therapeutics.

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.